Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc Logo
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 131.87 USD -0.04% Market Closed
Market Cap: 14B USD

Wall Street
Price Targets

ITCI Price Targets Summary
Intra-Cellular Therapies Inc

There are no price targets for ITCI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Intra-Cellular Therapies Inc Competitors:
Price Targets
128940
Hanmi Pharm Co Ltd
10% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
28% Upside
IMP
Imexpharm Corp
12% Upside
NATCOPHARM
Natco Pharma Ltd
2% Upside
AETHER
Aether Industries Ltd
24% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
28% Downside
249420
Il Dong Pharmaceutical Co Ltd
20% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Intra-Cellular Therapies Inc

For the last 12 years the compound annual growth rate for Intra-Cellular Therapies Inc's revenue is 57%. The projected CAGR for the next 3 years is 48%.

57%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Intra-Cellular Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Intra-Cellular Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ITCI's stock price target?
Not Available

ITCI doesn't have any price targets made by Wall Street professionals.

What is Intra-Cellular Therapies Inc's Revenue forecast?
Projected CAGR
48%

For the last 12 years the compound annual growth rate for Intra-Cellular Therapies Inc's revenue is 57%. The projected CAGR for the next 3 years is 48%.

Back to Top